Point72 Asset Management L.P. Has $7.14 Million Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Point72 Asset Management L.P. boosted its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 197.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 352,339 shares of the real estate investment trust's stock after buying an additional 233,839 shares during the quarter. Point72 Asset Management L.P. owned approximately 0.05% of Healthpeak Properties worth $7,142,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of DOC. Mizuho Bank Ltd. acquired a new stake in Healthpeak Properties in the 4th quarter worth $28,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Healthpeak Properties during the 4th quarter valued at about $30,000. Covestor Ltd boosted its position in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after acquiring an additional 1,152 shares in the last quarter. Kestra Investment Management LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter valued at about $45,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of Healthpeak Properties during the 4th quarter valued at about $46,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on DOC shares. StockNews.com lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Robert W. Baird cut their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Argus reaffirmed a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Wedbush dropped their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Scotiabank dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Healthpeak Properties presently has an average rating of "Moderate Buy" and an average target price of $23.45.

Insider Activity at Healthpeak Properties

In other news, Director Tommy G. Thompson acquired 5,700 shares of the firm's stock in a transaction that occurred on Friday, May 9th. The stock was purchased at an average price of $17.36 per share, for a total transaction of $98,952.00. Following the completion of the acquisition, the director now owns 138,513 shares in the company, valued at $2,404,585.68. This trade represents a 4.29% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Scott M. Brinker purchased 11,337 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The stock was bought at an average price of $17.68 per share, with a total value of $200,438.16. Following the acquisition, the chief executive officer now directly owns 201,863 shares of the company's stock, valued at approximately $3,568,937.84. This trade represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 23,987 shares of company stock worth $422,141. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Stock Down 0.1%

Shares of NYSE:DOC opened at $17.72 on Tuesday. Healthpeak Properties, Inc. has a one year low of $16.90 and a one year high of $23.26. The company has a 50 day moving average of $18.73 and a 200-day moving average of $20.01. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a market cap of $12.31 billion, a price-to-earnings ratio of 50.63, a P/E/G ratio of 2.17 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the previous year, the company earned $0.45 EPS. Healthpeak Properties's revenue was up 15.9% on a year-over-year basis. On average, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently declared a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be given a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend is Monday, May 19th. Healthpeak Properties's dividend payout ratio is 305.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.